Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Getting closer to lift off - patience folks
View:
Post by mdjbrown on Feb 25, 2022 10:28am

Getting closer to lift off - patience folks

Comment by subaru1 on Feb 25, 2022 11:13am
The company owns valuable IP and is executing on high-profile projects which provide it with substantial potential growth catalysts and believe our readers should be aware of the opportunity.  We are not aware of any of the projects unless you do and if so which one are they. Technical420.com are always pumping stocks with nice words but rarely with real stuff.
Comment by prone on Feb 26, 2022 11:38am
And ---> RE:The United States Supreme Court AND ---> As Bernie Sanders states ---> This session, advocates are focused on a marijuana descheduling bill that’s being led by Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ). After introducing a discussion draft of the legislation in July, the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities